Jerry Katzman, MD - Chairman, President & CEO
Dr. Jerry Katzman is the Company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Dr. Katzman has always been an entrepreneur, scientist, and pioneer in medical science. His focus has targeted various biotechnology companies, biopharma, and Wall Street. Upon completion of his medical training, Dr. Katzman joined a multi-specialty group practice in Brandon, FL where he founded and established the group’s department of ophthalmology.
He then entered into a private practice where he designed and built one of the first state-licensed in office freestanding ambulatory surgical centers. The center also provided a multitude of services, including pharmacy, audiology, retinal dx, and treatment, as well as, general eye care, eye surgery, and optical. In 1993, Dr. Katzman founded EyeCare International, the nation’s first and largest non-insurance based discount vision network consisting of over 13,000 provider locations.
After 17 years with Amacore Group, Inc. (successor to EyeCare International) retired as its Chief Medical Officer and continued his work on healthcare initiatives to promote affordable healthcare and an emergency electronic medical records program.
Thereafter, in 2008, co-founded Core Corporate Consulting Group, Inc. a private company designed to purchase and rejuvenate ailing public companies that were headed into bankruptcy.
In 2013, he founded Disruptor Technologies Inc., a marketing and consulting company, and served as the CEO. Disruptor was developed to research, identify, evaluate, obtain, develop, promote, manufacture, and/or market groundbreaking technologies in health and science.
Dr. Katzman is also the host of the podcast Healthy, Strong, and Active: Your Strategy for Life.
Dr. Katzman graduated from Boston University with a B.S. in Biomedical Engineering in 1974 and thereafter earned his M.D. from the Universidad de Guadalajara in Jalisco, Mexico.
Vinay Mehindru, MD, MBA - Medical Advisor and Member, Board of Directors
Dr. Mehindru is an accomplished physician executive with over 25 years of healthcare experience that includes population health, physician performance management, and building physician alliances with clinical and financial integration. He is well known for taking vision and transforming it into reality through sound strategy development and execution.
Despite his humble origins in North India, his accelerated track in education included starting college at the age of 14 and graduating from medical school at age 21 as one of the youngest graduates in the country. Moving to the United States he completed a Residency in Internal Medicine at the Cleveland Clinic and a second Residency in Emergency Medicine at the University of Florida. At the University of Texas, he received an MBA with honors.
Dr. Mehindru joined a private group of physicians and worked in a Level Two trauma center for 10 years. He has been an instructor for both Advanced Cardiovascular Life Support (ACLS) and Pediatric Advanced Life Support (PALS) for 16 years. As Chief Medical Officer at AdventHealth Waterman, he spearheaded the establishment of a new hospitalist program and received recognition for excellence in seven metrics under Partnerships for Patients. With a focus on population health management, he managed 40,000 covered lives made up of: a self-funded employee health plan, a commercial health plan, and Medicare beneficiaries.
In his continued passion to improve outcomes for patients, Dr. Mehindru led the initiatives between the two major health systems in the Tampa Bay, Florida area, consisting of an exclusive health and wellness innovation partner for the first planned “Smart Gigabit Community,” a Home Health Care company, and a Joint Venture with the largest local radiology physicians group including 16 outpatient imaging centers.
Herbert L Gould - Medical Advisor and Member, Board of Directors
Dr. Gould graduated from Bowdoin College and received an MD from Columbia’s College of Physicians and Surgeons. He served his internship at the 1stMedical Division, Bellevue Hospital and was a resident at the Manhattan Eye, Ear & Throat Hospital, where, as senior resident, he initiated the Contact Lens Clinic. He continued his medical studies at the Institute of Ophthalmology (London), Harvard Medical School, and the Downstate Medical Center, NY, where he received a corneal fellowship which included Moorfields Eye Hospital, London.
He was a co-founder of the Contact Lens Society of Ophthalmologists and the New York Intraocular Lens Implant Society. He was a founding member of the American Intraocular Lens Implant Society, now ASCRS, was elected to the International Intraocular Lens Implant Club (IIIC), and later was a founding member of the International Society of Refractive Surgery. Dr.
Gould was the founder and first president of the New York Keratorefractive Society. He has been a Teaching Fellow at State University of New York, was Assistant Clinical Professor in Ophthalmology at State University of New York (Downstate), Associate Clinical Professor at New York Medical College, and served as an Instructor at the American Academy of Ophthalmology.
Numerous presentations were made to professional associations in the US and throughout the world, including ophthalmological meetings in Athens, Prague, Stockholm, London, Vienna, Milan, Alexandria (Egypt), Shanghai, Korea, Algarve (Portugal) and Cannes, where he was also awarded a Bronze Medal from the Cannes Film Festival (Best Surgical Film: Corneal Transplant & Intra-Ocular Lens Implantation). He has published over 80 articles and chapters in professional books and journals.
He has numerous professional memberships.
He implanted the first intraocular lens in China with the IIIC. He trained in Russia and introduced radial keratotomy to the US and later helped develop the Lasik technique. He had one of the first lasers in NYC after FDA approval, and later helped set up the laser center at the New York Eye and Ear Infirmary. He served as a Major in the U.S. Air Force, where he served as a Flight Surgeon, for five years.